Adalimumab Treatment in a Case of Treatment-Resistant Acne Conglobata
-
Published:2024-06-13
Issue:
Volume:
Page:
-
ISSN:2564-7040
-
Container-title:European Journal of Therapeutics
-
language:
-
Short-container-title:Eur J Ther
Author:
Daye MuniseORCID,
Kaya Bulut ŞeymaORCID
Publisher
Pera Publishing
Reference6 articles.
1. Yiu ZZ, Madan V, Griffiths CE (2015) Acne conglobata and adalimumab: use of tumour necrosis factor-alpha antagonists in treatment-resistant acne conglobata, and review of the literature. Clin Exp Dermatol 40:383-386. https://doi.org/10.1111/ced.12540
2. Gollnick HP (2015) From new findings in acne pathogenesis to new approaches in treatment. J Eur Acad Dermatol Venereol 29 Suppl 5:1-7. https://doi.org/10.1111/jdv.13186
3. Graham GM, Farrar MD, Cruse-Sawyer JE, Holland KT, Ingham E (2004) Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol 150:421-428. https://doi.org/10.1046/j.1365-2133.2004.05762.x
4. Ferahbaş Kesikoğlu A (2020) Akne Klinik. Turkderm 54:4-8. https://doi.org/10.4274/turkderm.galenos.2020.26964
5. Nast A, Dréno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, Finlay AY, Haedersdal M, Lambert J, Layton A (2016) European evidence‐based (S3) guideline for the treatment of acne–update 2016–short version. J Eur Acad Dermatol Venereol. 30:1261-1268. https://doi.org/10.1111/jdv.13776